NCIt related terms : Anti-integrin Beta-1 Monoclonal Antibody OS2966;
NCIt definition : A humanized monoclonal antibody directed against the human integrin receptor beta-1
subunit (CD29), with potential antineoplastic activity. Upon administration, anti-integrin
beta-1 monoclonal antibody OS2966 targets and binds to integrin beta-1 on the surface
of tumor cells and macrophages in the tumor microenvironment (TME), thereby preventing
integrin beta-1-mediated activation of downstream signaling pathways. This may include
the blockade of the binding of integrin beta-1 to the effector kinase focal adhesion
kinase (FAK), preventing FAK-mediated activation of Stat1 and Akt. This may inhibit
tumor cell proliferation, invasion and migration in integrin beta-1-overexpressing
tumor cells. Integrin beta-1, the dominant subunit in all four classes of integrin
receptors, plays an important role in tumor cell proliferation, invasion, and drug
resistance.;